{"gene":"GLIS3","run_date":"2026-04-28T18:06:53","timeline":{"discoveries":[{"year":2003,"finding":"GLIS3 is an 83.8 kDa nuclear protein containing five C2H2-type Krüppel-like zinc finger motifs that can function as both a repressor and activator of transcription; it binds the GLI-RE consensus sequence and enhances GLI-RE-dependent transcription; deletion mutant analysis showed the N- and C-termini are required for optimal transcriptional activity.","method":"Reporter assays, deletion mutant analysis, DNA-binding assays, whole-mount in situ hybridization","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — multiple in vitro assays and mutagenesis in original characterization paper","pmids":["14500813"],"is_preprint":false},{"year":2006,"finding":"Loss-of-function mutations in GLIS3 (frameshift and large deletions) cause neonatal diabetes and congenital hypothyroidism; GLIS3 is expressed preferentially in pancreatic beta cells and thyroid from early developmental stages, establishing its role in beta cell and thyroid development.","method":"Human genetic mutation identification, gene expression analysis (tissue-specific transcripts)","journal":"Nature genetics","confidence":"High","confidence_rationale":"Tier 2 — human loss-of-function mutations with defined organ-specific phenotypes, multiple families","pmids":["16715098"],"is_preprint":false},{"year":2008,"finding":"The fourth zinc finger tetrahedral configuration is essential for nuclear localization of GLIS3 (not the putative bipartite NLS); all five zinc finger motifs are critical for efficient DNA binding; the consensus high-affinity Glis3 DNA-binding site is (G/C)TGGGGGGT(A/C); the C-terminus contains the transactivation domain; the NDH1 frameshift mutation truncates the C-terminus, abolishing transactivating activity without affecting nuclear localization.","method":"Deletion mutant analysis, EMSA (electrophoretic mobility shift assay), reporter transcription assays, mutagenesis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — in vitro binding assays, mutagenesis, and functional reporter assays with multiple mutants","pmids":["18263616"],"is_preprint":false},{"year":2009,"finding":"GLIS3 localizes to the primary cilium as well as the nucleus; GLIS3 interacts with the transcriptional coactivator Wwtr1/TAZ via a P/LPXY motif in the GLIS3 C-terminus; Wwtr1 enhances GLIS3-mediated transcriptional activation; mutations in the P/LPXY motif abrogate both Wwtr1 interaction and transcriptional activity; Glis3-deficient mice develop polycystic kidney disease.","method":"Co-immunoprecipitation, subcellular localization (confocal imaging), reporter assays, mutagenesis, mouse knockout model","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — reciprocal co-IP, mutagenesis, direct localization, and functional transcription assays","pmids":["19273592"],"is_preprint":false},{"year":2009,"finding":"Glis3 directly binds the insulin 2 (Ins2) promoter at a Glis3 response element (5'-GTCCCCTGCTGTGAA-3', positions -255 to -241) via its zinc finger region; Glis3 physically and functionally interacts with Pdx1, MafA, and NeuroD1 to modulate Ins2 promoter activity; Glis3 also upregulates MafA and downregulates Nkx6-1.","method":"Chromatin immunoprecipitation (ChIP), EMSA, reporter/deletion assays, co-immunoprecipitation, siRNA knockdown","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP, EMSA, and functional reporter assays with multiple orthogonal methods","pmids":["19264802"],"is_preprint":false},{"year":2009,"finding":"Glis3-deficient mice exhibit neonatal diabetes due to impaired islet development and decreased insulin mRNA, establishing GLIS3 as essential for insulin-producing cell formation in vivo.","method":"Gene-targeted knockout mouse, blood glucose measurement, insulin mRNA quantification, histology","journal":"FEBS letters","confidence":"High","confidence_rationale":"Tier 2 — clean KO with defined cellular phenotype, corroborated by additional KO papers","pmids":["19481545"],"is_preprint":false},{"year":2011,"finding":"GLIS3 directly binds specific GLIS3-response elements in the Neurogenin 3 (Neurog3/Ngn3) promoter and activates Neurog3 transcription; GLIS3 acts synergistically with Hnf6 and FoxA2 to activate Ngn3, placing GLIS3 upstream of Neurog3 in the endocrine pancreas differentiation hierarchy.","method":"In vivo genetic analysis (Glis3-/- mouse), ChIP, promoter reporter assays, epistasis, in vitro reconstitution","journal":"Diabetologia","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP, reporter assays, and in vivo epistasis across multiple methods","pmids":["21786021"],"is_preprint":false},{"year":2011,"finding":"SUFU interacts with GLIS3 through a VYGHF motif in the conserved N-terminal region of GLIS3; SUFU inhibits GLIS3-mediated insulin promoter activation in a binding-dependent manner; SUFU promotes nuclear accumulation of itself when GLIS3 is present; SUFU stabilizes GLIS3 by antagonizing a Cullin 3-based E3 ubiquitin ligase that ubiquitinates and degrades GLIS3.","method":"Co-immunoprecipitation, reporter assays, mutagenesis, ubiquitination assays, subcellular localization","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 — multiple orthogonal methods including co-IP, ubiquitination assay, and functional reporter assays","pmids":["21543335"],"is_preprint":false},{"year":2007,"finding":"GLIS3 promotes osteoblast differentiation in multipotent C3H10T1/2 cells, acts synergistically with BMP2 and Shh, and induces FGF18 expression via a Glis3 binding site in the FGF18 promoter flanking region; the C-terminal activation function is required for this effect.","method":"Microarray, reporter assays, EMSA, alkaline phosphatase activity, siRNA/overexpression","journal":"Journal of bone and mineral research","confidence":"Medium","confidence_rationale":"Tier 2 — EMSA and reporter assays with functional cellular readout, single lab","pmids":["17488195"],"is_preprint":false},{"year":2012,"finding":"Glis3 directly interacts with Hnf6 in vitro and in vivo; the Glis3 N-terminus and the Hnf6 homeodomain are required for this interaction; both proteins cooperatively activate Ngn3 transcription through the distal Ngn3 promoter region.","method":"Co-immunoprecipitation, in vitro binding assay, ChIP, reporter assays, deletion/mutagenesis","journal":"Molecules and cells","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro and in vivo binding assays plus functional ChIP and reporter assays","pmids":["22820919"],"is_preprint":false},{"year":2012,"finding":"Sustained GLIS3 expression in adult beta cells is required for insulin expression and beta cell mass maintenance; GLIS3 controls beta cell proliferation in response to high-fat diet by regulating Ccnd2 (Cyclin D2) transcription.","method":"Conditional knockout mouse (Glis3fl/fl/Pdx1CreERT+), tamoxifen induction, glucose tolerance testing, gene expression analysis","journal":"EMBO molecular medicine","confidence":"High","confidence_rationale":"Tier 2 — conditional KO with defined cellular phenotype and molecular mechanism","pmids":["23197416"],"is_preprint":false},{"year":2013,"finding":"GLIS3 knockdown increases beta cell apoptosis via the intrinsic (mitochondrial) pathway (cytochrome c release, Bax translocation, caspase 9/3 activation); GLIS3 loss promotes alternative splicing of the pro-apoptotic BH3-only protein Bim, favouring the pro-death variant BimS via inhibition of the splicing factor SRp55; KD of Bim abrogates the pro-apoptotic effect of GLIS3 loss.","method":"siRNA knockdown in INS-1E cells, primary rat beta cells and human islets; cytochrome c fractionation; Bax translocation; caspase activity assays; RT-PCR for splice variants","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple cell models, orthogonal apoptosis readouts, and rescue experiment with Bim KD","pmids":["23737756"],"is_preprint":false},{"year":2013,"finding":"GLIS3 binding to GlisBS in the insulin promoter is required as a scaffold for the stable association of Pdx1, NeuroD1, and MafA with the insulin promoter; GLIS3 recruits CBP/p300 to form a larger transcriptional regulatory complex; GlisBS mutation prevents stable Pdx1 and MafA binding and reduces insulin promoter activation by all three factors.","method":"ChIP, reporter assays, siRNA knockdown, GlisBS mutagenesis, co-immunoprecipitation","journal":"Molecular endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP with mutant promoter, co-IP, and functional reporter assays demonstrating scaffold mechanism","pmids":["23927931"],"is_preprint":false},{"year":2015,"finding":"The HECT E3 ubiquitin ligase Itch interacts with GLIS3 through WW domain–PPxY motif interaction in the GLIS3 N-terminus, polyubiquitinates GLIS3, and enhances its proteasomal degradation, thereby inhibiting GLIS3-mediated transactivation and endogenous Ins2 expression; Itch-mediated degradation requires both the PPxY motif and GLIS3 zinc finger domains.","method":"Mass spectrometry, yeast 2-hybrid, co-immunoprecipitation, ubiquitination assays, proteasome inhibitor experiments, reporter assays, mutagenesis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 1–2 — mass spectrometry, co-IP, ubiquitination assay, and functional reporter assays with multiple mutants","pmids":["26147758"],"is_preprint":false},{"year":2016,"finding":"Glis3 is expressed in bipotent progenitors in the trunk domain (co-localizing with Sox9, Hnf6, Pdx1), in Ngn3+ endocrine progenitors, and in mature beta, PP, and ductal cells (but not in multipotent tip progenitors); Glis3-deficiency reduces and exogenous Glis3 induces Ppy (pancreatic polypeptide) expression.","method":"Glis3-EGFP knockin mouse, immunohistochemistry, live imaging, co-localization analysis","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — direct localization via knockin reporter with functional consequence","pmids":["27270601"],"is_preprint":false},{"year":2016,"finding":"GLIS3 is expressed in gonocytes, spermatogonial stem cells (SSCs), and spermatogonial progenitors; loss of GLIS3 impairs gonocyte-to-SSC transition and inhibits cytoplasmic-to-nuclear translocation of FOXO1 (a marker of gonocyte-to-SSC transition required for SSC self-renewal).","method":"GLIS3 knockout mice, gene expression profiling, immunohistochemistry, FOXO1 localization assay","journal":"Stem cells","confidence":"High","confidence_rationale":"Tier 2 — KO with defined cellular phenotype and mechanistic link to FOXO1 localization","pmids":["27350140"],"is_preprint":false},{"year":2017,"finding":"GLIS3 acts downstream of TSH/TSHR signaling and is indispensable for TSH/TSHR-mediated thyroid follicular cell proliferation and thyroid hormone biosynthesis; ChIP-Seq showed GLIS3 directly binds and activates promoters of Nis (Slc5a5) and Pds (Slc26a4) iodide transporters; GLIS3 deficiency inhibits mTORC1/RPS6 pathway activation downstream of TSH, suppressing cell division.","method":"GLIS3-deficient mouse model, ChIP-Seq, promoter analysis, mTORC1/RPS6 signaling assays, proliferation assays","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-Seq, pathway analysis, and in vivo KO with defined cellular phenotype","pmids":["29083325"],"is_preprint":false},{"year":2018,"finding":"SUMO modification of GLIS3 at two conserved lysine residues in the N-terminus, mediated by PIASy and Ubc9, dramatically inhibits GLIS3-mediated insulin transcription; SUMOylation of GLIS3 is increased under chronically elevated glucose conditions and correlates with decreased insulin transcription.","method":"SUMOylation assays, reporter assays, mutagenesis of lysine residues, glucose treatment experiments","journal":"Heliyon","confidence":"Medium","confidence_rationale":"Tier 1–2 — in vitro SUMO modification with mutagenesis and functional reporter assay, single lab","pmids":["30094379"],"is_preprint":false},{"year":2018,"finding":"GLIS3 directly activates WNT gene transcription (including WNT3A) in human embryonic stem cells, driving their differentiation toward posterior neural progenitor cells; inhibition of WNT signaling abrogates GLIS3-induced posterior specification.","method":"RNA-Seq, ChIP-Seq, functional reporter assays, WNT inhibition rescue experiments, hESC differentiation","journal":"Stem cells","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-Seq, RNA-Seq, and pharmacological rescue experiment with orthogonal methods","pmids":["30376208"],"is_preprint":false},{"year":2018,"finding":"Loss of GLIS3 in hESC-derived pancreatic progenitors causes beta-cell death by activating the TGFβ pathway; a drug screen identified a compound that rescues GLIS3-/- associated beta-cell death in vitro and in vivo.","method":"GLIS3-/- hESC directed differentiation, high-content chemical screen, TGFβ pathway analysis, in vivo xenograft","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — human stem cell KO with pathway identification and in vivo rescue","pmids":["29992946"],"is_preprint":false},{"year":2019,"finding":"GLIS3 binds pancreatic beta cell regulatory regions that coincide with binding sites for other islet-enriched transcription factors; ChIP-Seq combined with RNA-Seq revealed direct regulation of Slc2a2 (Glut2) and Mafa by GLIS3 in addition to Ins2 and Ngn3; loss of GLIS3 in beta cells produces PDX1+/INS-/MAFA-/GLUT2- cells without increased cell death.","method":"Pancreas-specific Glis3 conditional KO, GLIS3 ChIP-Seq, islet RNA-Seq, immunohistochemistry","journal":"The Journal of endocrinology","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-Seq and RNA-Seq with conditional KO mouse model","pmids":["31340201"],"is_preprint":false},{"year":2019,"finding":"GLIS3 is required for self-renewal of adult murine pancreatic colony-forming units (PCFUs); GLIS3 maintains WNT receptor and signaling molecule expression (a GLIS3-CD133-WNT axis); CD133 (but not GLIS3 or WNT) is required for PI3K/AKT-mediated PCFU survival.","method":"shRNA knockdown in sorted CD133highCD71low ductal cells, ex vivo colony/organoid assays, gene expression analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2–3 — KD in primary cells with colony assay readout, single lab","pmids":["31533988"],"is_preprint":false},{"year":2018,"finding":"Loss of Glis3 in fetal male germ cells causes widespread reduction in retrotransposon silencing factors and aberrant retrotransposon expression; precocious Glis3 expression in vivo results in premature expression of piRNA pathway members, indicating GLIS3 is necessary for activation of retrotransposon silencing programs.","method":"Glis3 KO mouse, gene expression profiling, in vivo transgenic induction of Glis3","journal":"Scientific reports","confidence":"Medium","confidence_rationale":"Tier 2 — KO and gain-of-function in vivo with defined molecular phenotype, single lab","pmids":["29941866"],"is_preprint":false},{"year":2023,"finding":"GLIS3 co-regulates transcription of thyroid hormone biosynthetic genes (including Slc5a5/Nis, Slc26a4, Cdh16, Adm2) by binding within the same regulatory regions as PAX8, NKX2.1, and FOXE1; loss of GLIS3 does not significantly alter PAX8 or NKX2.1 binding or H3K4me3/H3K27me3 epigenetic marks, suggesting GLIS3 activates transcription by enhancing interactions with enhancers and/or RNA Pol II complexes rather than restructuring chromatin.","method":"PAX8/NKX2.1/FOXE1 ChIP-Seq in mouse thyroid and PCCl3 cells, comparison to GLIS3 cistrome, ChIP-QPCR, histone mark analysis in Glis3KO","journal":"Cell & bioscience","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-Seq with multiple TFs and KO mouse, orthogonal epigenomic analysis","pmids":["36793061"],"is_preprint":false},{"year":2024,"finding":"GLIS3 directly regulates genes critical for mitochondrial biogenesis, OXPHOS, fatty acid oxidation, and TCA cycle in kidney (including Tfam, Ppargc1a/b, Hadha, Sdha); GLIS3 ChIP-Seq showed binding near these genes; GLIS3 binding loci frequently co-localize with HNF1B and NRF1; loss of GLIS3 causes metabolic reprogramming toward aerobic glycolysis and glutamine anaplerosis in kidney.","method":"Transcriptomics, ChIP-Seq (cistromics), untargeted metabolomics, Seahorse analysis, tissue-specific KO mice","journal":"Molecular metabolism","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-Seq, metabolomics, and functional Seahorse assay in KO model, multiple orthogonal methods","pmids":["39505148"],"is_preprint":false},{"year":2024,"finding":"GLIS3 directly represses Pkm (pyruvate kinase M) expression in kidney; loss of GLIS3 elevates PKM2 dimer-promoting phosphorylations (Y105, S37) and increases aerobic glycolysis; pharmacological inhibition of PKM2 in GLIS3-deficient cultures and kidneys reduces cyst growth, linking GLIS3-mediated glycolytic repression to cystogenesis.","method":"Transcriptomics, ChIP-Seq, siRNA knockdown, phosphorylation analysis, PKM2 inhibitor treatment, spheroid/cyst assays","journal":"Experimental & molecular medicine","confidence":"High","confidence_rationale":"Tier 1–2 — ChIP-Seq, KO models, pharmacological rescue, and multiple orthogonal readouts","pmids":["41826646"],"is_preprint":false},{"year":2020,"finding":"In zebrafish, glis3 is required for early thyroid primordium specification; glis3 morphants show reduced nkx2.4 and pax2a expression at the thyroid primordium; glis3 functions as an effector of the Sonic Hedgehog (SHH) pathway in thyroid development; pharmacological SHH inhibition reproduces thyroid defects seen in glis3 morphants.","method":"Morpholino knockdown in zebrafish, in situ hybridization, immunohistochemistry, pharmacological SHH inhibition","journal":"Thyroid","confidence":"Medium","confidence_rationale":"Tier 2 — morpholino KD with molecular pathway rescue, zebrafish ortholog","pmids":["31797737"],"is_preprint":false},{"year":2020,"finding":"The PAX8-GLIS3 fusion oncogene (exons 1-2 of PAX8 fused to exons 3-11 of GLIS3) increases proliferation, clonogenic potential, and migration of thyroid and HEK-293 cells; these oncogenic effects are mediated through activation of the Sonic Hedgehog (SHH) pathway; SMO inhibitor cyclopamine partially reverses these effects.","method":"Forced expression in cell lines, proliferation/migration assays, xenograft models, SHH pathway inhibition","journal":"International journal of cancer","confidence":"High","confidence_rationale":"Tier 2 — in vitro functional assays, in vivo xenograft, and pharmacological pathway rescue","pmids":["32383186"],"is_preprint":false},{"year":2023,"finding":"CircGlis3, derived from exon 4 of Glis3, promotes beta-cell dysfunction by: (1) binding hnRNPF and blocking its nuclear translocation, thereby reducing Sirt1 levels; (2) encoding a 348aa protein that interacts with GLIS3 and inhibits its transcriptional activity; CELF1 facilitates biogenesis of circGlis3.","method":"Transgenic mouse model, RNA pulldown, protein interaction assays, nuclear fractionation, CRISPR overexpression","journal":"iScience","confidence":"Medium","confidence_rationale":"Tier 2–3 — in vivo transgenic model and molecular interaction assays, single lab","pmids":["38226164"],"is_preprint":false},{"year":2024,"finding":"Glis3 acts as a pioneer-like factor at the insulin promoter, permissively remodeling chromatin to allow access by Pdx1 and MafA; Glis3 positively regulates MafA transcription through its pancreas-specific promoter; MafA reciprocally regulates Glis3 expression; Glis3 is downregulated by oxidative stress in glucotoxic conditions.","method":"CRISPR/Cas9 knockdown, chromatin accessibility assays, reporter assays, gene expression analysis in INS1 cells under high glucose","journal":"Islets","confidence":"Medium","confidence_rationale":"Tier 2–3 — chromatin remodeling evidence and reciprocal regulation assays, single lab","pmids":["38652652"],"is_preprint":false},{"year":2026,"finding":"GLIS3 is a key transcriptional regulator of an inflammation-fibrosis cell circuit in intestinal fibroblasts; fibroblast-specific deletion of Glis3 in mice alleviates chronic colitis; GLIS3 governs expression of inflammatory and fibrotic genes in inflammation-associated fibroblasts induced by FCN1+IL1B+ macrophages, which in turn produce profibrotic IL-11.","method":"Genome-wide CRISPR knockout and activation screens, fibroblast-specific conditional KO mouse, single-cell and spatial transcriptomics, colitis model","journal":"Nature","confidence":"High","confidence_rationale":"Tier 1–2 — genome-wide CRISPR screens, conditional KO with disease model, and spatial transcriptomics","pmids":["41501466"],"is_preprint":false},{"year":2025,"finding":"Alternative splicing of mouse Glis3 produces a shorter isoform lacking exon 3 (659 aa vs. 935 aa); the shorter isoform is expressed at higher levels in all mouse tissues, is more stable, and exhibits greater transactivation potential; mass spectrometry identified phosphorylation sites and co-activator/co-repressor complex members (including known members) as GLIS3 interactors.","method":"RT-PCR, isoform-specific expression analysis, stability assays, reporter assays, mass spectrometry","journal":"Cells","confidence":"Medium","confidence_rationale":"Tier 2–3 — functional isoform comparison with mass spectrometry, single lab","pmids":["41369402"],"is_preprint":false}],"current_model":"GLIS3 is a Krüppel-like zinc finger transcription factor that localizes to both the nucleus and primary cilia; it activates or represses transcription by binding the consensus sequence (G/C)TGGGGGGT(A/C) through all five zinc fingers, with the C-terminus providing transactivation activity that is regulated by post-translational modifications (ubiquitination by Itch/Cullin3-E3, SUMOylation by PIAS/Ubc9) and by interaction with SUFU (which stabilizes GLIS3 against Cullin3-mediated degradation); in pancreatic beta cells GLIS3 serves as a scaffold recruiting CBP/p300, Pdx1, MafA, and NeuroD1 to the insulin promoter for transcriptional activation, directly transactivates Ngn3 (in cooperation with Hnf6 and FoxA2) to drive endocrine progenitor specification, and controls beta cell survival by regulating alternative splicing of pro-apoptotic Bim via SRp55; in thyroid follicular cells GLIS3 acts downstream of TSH/TSHR to activate iodide transporter genes (Nis, Pds) in coordination with PAX8, NKX2.1, and FOXE1, and drives mTORC1-dependent proliferation; in kidney, GLIS3 directly regulates mitochondrial biogenesis, OXPHOS, and fatty acid oxidation genes (in concert with HNF1B and NRF1), and suppresses PKM2-driven aerobic glycolysis, with loss of GLIS3 causing metabolic reprogramming that promotes cystogenesis; and in intestinal fibroblasts GLIS3 regulates an inflammatory-fibrotic gene network downstream of macrophage-derived signals."},"narrative":{"teleology":[{"year":2003,"claim":"Identification of GLIS3 as a dual-function Krüppel-like zinc finger transcription factor that binds GLI-response elements established the molecular framework for all subsequent functional studies.","evidence":"Reporter assays, deletion mutant analysis, DNA-binding assays, and in situ hybridization in the original characterization paper","pmids":["14500813"],"confidence":"High","gaps":["No endogenous target genes identified","No in vivo function demonstrated","No post-translational regulation characterized"]},{"year":2006,"claim":"Discovery that loss-of-function GLIS3 mutations cause neonatal diabetes and congenital hypothyroidism in humans established its essential non-redundant role in beta cell and thyroid development, directing subsequent mechanistic work toward these tissues.","evidence":"Identification of frameshift and large deletions in multiple consanguineous families with neonatal diabetes and hypothyroidism","pmids":["16715098"],"confidence":"High","gaps":["Molecular targets in beta cells and thyroid unknown","Developmental stage of GLIS3 requirement undefined"]},{"year":2008,"claim":"Mapping of the DNA-binding determinants (all five zinc fingers required, consensus (G/C)TGGGGGGT(A/C)) and localization of the transactivation domain to the C-terminus explained how the human NDH1 frameshift mutation causes disease — by truncating transactivation while preserving nuclear localization.","evidence":"EMSA with systematic zinc finger mutants, reporter assays with deletion constructs, analysis of NDH1 mutation","pmids":["18263616"],"confidence":"High","gaps":["No genome-wide binding data","No crystal structure of zinc finger–DNA complex"]},{"year":2009,"claim":"Demonstration that GLIS3 directly binds the insulin promoter and physically interacts with Pdx1, MafA, and NeuroD1 provided the first mechanistic explanation for how GLIS3 loss causes neonatal diabetes, while concurrent work showed GLIS3 localizes to primary cilia and interacts with Wwtr1/TAZ, linking it to cilia-dependent signaling and polycystic kidney disease.","evidence":"ChIP, EMSA, co-IP, reporter assays (insulin promoter); confocal localization to cilia; Glis3 KO mouse developing PKD","pmids":["19264802","19273592","19481545"],"confidence":"High","gaps":["Whether GLIS3 acts as a scaffold versus simple activator at the insulin promoter was not resolved","Cilia-to-nucleus signaling mechanism unknown","Wwtr1/TAZ contribution in vivo untested"]},{"year":2011,"claim":"Placing GLIS3 upstream of Neurogenin 3 in the endocrine differentiation hierarchy — via direct promoter binding and synergy with Hnf6 and FoxA2 — and identifying SUFU as a stabilizer that antagonizes Cullin3-mediated GLIS3 degradation revealed both a developmental circuit and a proteostatic control mechanism.","evidence":"ChIP and reporter assays on Ngn3 promoter with epistasis in Glis3−/− mice; co-IP, ubiquitination assays, and mutagenesis for SUFU/Cullin3 axis","pmids":["21786021","21543335"],"confidence":"High","gaps":["Identity of the Cullin3 adaptor for GLIS3 unknown","Whether SUFU regulation occurs in primary cilia unresolved","In vivo significance of SUFU–GLIS3 interaction in beta cells untested"]},{"year":2012,"claim":"Conditional deletion in adult beta cells proved that GLIS3 is continuously required — not just developmentally — for insulin expression and beta cell mass maintenance, including proliferative adaptation to metabolic stress via Cyclin D2 regulation.","evidence":"Tamoxifen-inducible Glis3 conditional KO in adult mice, glucose tolerance testing, Ccnd2 expression analysis","pmids":["23197416","22820919"],"confidence":"High","gaps":["Whether GLIS3 directly binds the Ccnd2 promoter not shown by ChIP","Mechanism linking GLIS3 loss to proliferative failure beyond Ccnd2 unclear"]},{"year":2013,"claim":"Two mechanistic advances resolved how GLIS3 controls beta cell fate: it functions as an obligate scaffold at the insulin promoter (recruiting CBP/p300 for stable Pdx1/MafA association), and its loss triggers beta cell apoptosis through SRp55-mediated alternative splicing of pro-apoptotic Bim — an unexpected splicing-regulatory function.","evidence":"GlisBS mutagenesis with ChIP showing loss of Pdx1/MafA binding; Bim splice variant analysis with SRp55 mechanism and Bim-KD rescue in INS-1E, primary rat beta cells, and human islets","pmids":["23927931","23737756"],"confidence":"High","gaps":["How GLIS3 regulates SRp55 expression or activity unknown","Whether the scaffold function is unique to the insulin promoter or general"]},{"year":2015,"claim":"Identification of Itch as a second E3 ubiquitin ligase for GLIS3 (acting via N-terminal PPxY motifs) complemented the earlier Cullin3 finding, revealing dual proteolytic control of GLIS3 protein levels that tunes insulin gene output.","evidence":"Mass spectrometry, yeast two-hybrid, co-IP, ubiquitination assays, proteasome inhibitor experiments, and mutagenesis","pmids":["26147758"],"confidence":"High","gaps":["Relative contributions of Itch vs. Cullin3 in beta cells in vivo unknown","No deubiquitinase identified"]},{"year":2017,"claim":"ChIP-Seq in thyroid placed GLIS3 downstream of TSH/TSHR signaling as a direct activator of iodide transporter genes (Nis, Pds) and revealed that GLIS3 is required for mTORC1-dependent thyroid proliferation, providing a molecular explanation for congenital hypothyroidism.","evidence":"GLIS3 ChIP-Seq in thyroid, mTORC1/RPS6 signaling analysis, and Glis3-deficient mouse thyroid phenotyping","pmids":["29083325"],"confidence":"High","gaps":["How TSH signaling induces GLIS3 expression or activity unknown","mTORC1 activation mechanism downstream of GLIS3 not defined"]},{"year":2018,"claim":"SUMOylation of GLIS3 at conserved N-terminal lysines (by PIASy/Ubc9) was shown to inhibit insulin transcription under chronic high-glucose conditions, providing a post-translational mechanism linking glucotoxicity to beta cell dysfunction; concurrently, GLIS3 loss in hESC-derived beta cells was shown to activate TGFβ-mediated cell death, identifying a druggable pathway.","evidence":"SUMOylation assays with mutagenesis under variable glucose; GLIS3−/− hESC differentiation with chemical screen and xenograft rescue","pmids":["30094379","29992946"],"confidence":"High","gaps":["SUMO site occupancy in native beta cells not measured","Identity of TGFβ ligands and receptors mediating GLIS3−/− beta cell death unresolved","Drug target specificity not fully defined"]},{"year":2019,"claim":"Genome-wide ChIP-Seq in beta cells expanded the direct GLIS3 target repertoire to include Slc2a2/Glut2 and MafA, showing that GLIS3 loss produces a PDX1+/INS−/MAFA−/GLUT2− dedifferentiated beta cell state rather than simply causing cell death, reshaping the understanding of GLIS3-associated diabetes pathogenesis.","evidence":"GLIS3 ChIP-Seq and RNA-Seq in islets from pancreas-specific conditional KO mice","pmids":["31340201"],"confidence":"High","gaps":["Whether dedifferentiated cells can be re-differentiated by GLIS3 restoration untested","Distinction between dedifferentiation and alternative cell fate not resolved"]},{"year":2023,"claim":"Integration of GLIS3, PAX8, NKX2.1, and FOXE1 cistromes in thyroid revealed extensive co-occupancy at thyroid gene regulatory regions; GLIS3 loss did not alter co-factor binding or histone marks, suggesting GLIS3 activates transcription by enhancing enhancer–promoter communication or Pol II recruitment rather than restructuring chromatin.","evidence":"Multi-TF ChIP-Seq in mouse thyroid and PCCl3 cells, histone mark ChIP-qPCR in Glis3 KO","pmids":["36793061"],"confidence":"High","gaps":["Enhancer–promoter looping assays (e.g., HiChIP) not performed","Whether this non-chromatin-remodeling mechanism applies in beta cells unknown"]},{"year":2024,"claim":"Discovery that GLIS3 directly controls mitochondrial biogenesis, OXPHOS, and fatty acid oxidation genes in kidney — co-binding with HNF1B and NRF1 — and that GLIS3 loss causes metabolic reprogramming toward aerobic glycolysis (via PKM2 de-repression) that drives cystogenesis, established a metabolic mechanism for GLIS3-associated polycystic kidney disease and a pharmacological target (PKM2 inhibition).","evidence":"ChIP-Seq, untargeted metabolomics, Seahorse respirometry, and PKM2 inhibitor rescue in tissue-specific KO mice and spheroid cultures","pmids":["39505148","41826646"],"confidence":"High","gaps":["Whether the metabolic switch is reversible in vivo with GLIS3 restoration not tested","Contribution of other glycolytic enzymes beyond PKM2 unclear","HNF1B and NRF1 functional interdependence with GLIS3 not dissected by combinatorial KO"]},{"year":2026,"claim":"Genome-wide CRISPR screens identified GLIS3 as a key transcriptional regulator of an inflammatory-fibrotic gene network in intestinal fibroblasts, extending its role beyond endocrine and renal tissues; fibroblast-specific Glis3 deletion alleviated chronic colitis, establishing GLIS3 as a driver of inflammation-associated fibrosis.","evidence":"CRISPR KO/activation screens, fibroblast-specific conditional KO mouse, single-cell and spatial transcriptomics in colitis model","pmids":["41501466"],"confidence":"High","gaps":["Direct GLIS3 target genes in fibroblasts not defined by ChIP","Upstream signals (beyond FCN1+IL1B+ macrophages) inducing GLIS3 in fibroblasts unknown","Relevance to human inflammatory bowel disease not established"]},{"year":null,"claim":"Major unresolved questions include: the structural basis of GLIS3–DNA interaction and how its five zinc fingers cooperate; the cilia-to-nucleus signaling pathway that regulates GLIS3 processing or activation; and whether the metabolic, splicing-regulatory, and chromatin-remodeling functions of GLIS3 operate through common or distinct co-factor complexes across tissues.","evidence":"","pmids":[],"confidence":"Low","gaps":["No crystal or cryo-EM structure of GLIS3 zinc finger domain bound to DNA","Ciliary signaling mechanism for GLIS3 activation entirely undefined","Tissue-specific co-factor repertoire not systematically compared"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[0,2,4,6,12,16,20,24,25]},{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[0,2,4,6,10,12,16,18,20,23,24,25,30]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,2,3,4,12]},{"term_id":"GO:0005929","term_label":"cilium","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,2,4,6,10,12,16,18,20,23,24,25,30]},{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[1,5,6,14,15,26]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[16,18,19,21,27]},{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[7,13,17]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[24,25]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[11,19]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[1,27,30]}],"complexes":[],"partners":["PDX1","MAFA","NEUROD1","HNF6","FOXA2","SUFU","WWTR1","ITCH"],"other_free_text":[]},"mechanistic_narrative":"GLIS3 is a Krüppel-like zinc finger transcription factor that functions as a master regulator of pancreatic beta cell development and function, thyroid hormone biosynthesis, renal metabolic homeostasis, and intestinal fibroblast inflammatory programming. It binds the consensus sequence (G/C)TGGGGGGT(A/C) through five C2H2-type zinc fingers, with the C-terminus providing transactivation activity; at the insulin promoter, GLIS3 acts as a scaffold recruiting CBP/p300, Pdx1, MafA, and NeuroD1, and it drives endocrine progenitor specification by directly transactivating Neurogenin 3 in cooperation with Hnf6 and FoxA2 [PMID:14500813, PMID:19264802, PMID:23927931, PMID:21786021]. GLIS3 protein stability and transcriptional output are tuned by ubiquitination (via Itch and Cullin3-based E3 ligases, antagonized by SUFU) and SUMOylation (via PIASy/Ubc9), and in beta cells GLIS3 loss promotes apoptosis through alternative splicing of pro-apoptotic Bim via SRp55 [PMID:21543335, PMID:26147758, PMID:30094379, PMID:23737756]. Loss-of-function mutations in GLIS3 cause neonatal diabetes and congenital hypothyroidism in humans; in thyroid, GLIS3 operates downstream of TSH/TSHR to co-activate iodide transporter genes with PAX8, NKX2.1, and FOXE1, and in kidney it directly controls mitochondrial biogenesis, oxidative phosphorylation, and fatty acid oxidation genes while repressing PKM2-driven aerobic glycolysis, with its loss causing cystogenesis [PMID:16715098, PMID:29083325, PMID:36793061, PMID:39505148, PMID:41826646]."},"prefetch_data":{"uniprot":{"accession":"Q8NEA6","full_name":"Zinc finger protein GLIS3","aliases":["GLI-similar 3","Zinc finger protein 515"],"length_aa":775,"mass_kda":83.6,"function":"Acts both as a repressor and an activator of transcription. Binds to the consensus sequence 5'-GACCACCCAC-3' (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8NEA6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/GLIS3","classification":"Not Classified","n_dependent_lines":1,"n_total_lines":1208,"dependency_fraction":0.0008278145695364238},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/GLIS3","total_profiled":1310},"omim":[{"mim_id":"617038","title":"LONG INTERGENIC NONCODING RNA 1370; LINC01370","url":"https://www.omim.org/entry/617038"},{"mim_id":"610199","title":"DIABETES MELLITUS, NEONATAL, WITH CONGENITAL HYPOTHYROIDISM; NDH","url":"https://www.omim.org/entry/610199"},{"mim_id":"610192","title":"GLIS FAMILY ZINC FINGER PROTEIN 3; GLIS3","url":"https://www.omim.org/entry/610192"},{"mim_id":"607392","title":"WW DOMAIN-CONTAINING TRANSCRIPTION REGULATOR 1; WWTR1","url":"https://www.omim.org/entry/607392"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Approved","locations":[{"location":"Nucleoplasm","reliability":"Approved"},{"location":"Golgi apparatus","reliability":"Additional"},{"location":"Primary cilium","reliability":"Additional"}],"tissue_specificity":"Tissue enhanced","tissue_distribution":"Detected in many","driving_tissues":[{"tissue":"thyroid gland","ntpm":14.0}],"url":"https://www.proteinatlas.org/search/GLIS3"},"hgnc":{"alias_symbol":["MGC33662"],"prev_symbol":["ZNF515"]},"alphafold":{"accession":"Q8NEA6","domains":[{"cath_id":"3.30.160.60","chopping":"343-408","consensus_level":"medium","plddt":84.925,"start":343,"end":408},{"cath_id":"3.30.160.60","chopping":"410-466","consensus_level":"medium","plddt":89.7523,"start":410,"end":466},{"cath_id":"-","chopping":"469-508","consensus_level":"medium","plddt":83.2537,"start":469,"end":508}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NEA6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NEA6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8NEA6-F1-predicted_aligned_error_v6.png","plddt_mean":49.09},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=GLIS3","jax_strain_url":"https://www.jax.org/strain/search?query=GLIS3"},"sequence":{"accession":"Q8NEA6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8NEA6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8NEA6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8NEA6"}},"corpus_meta":[{"pmid":"16715098","id":"PMC_16715098","title":"Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism.","date":"2006","source":"Nature genetics","url":"https://pubmed.ncbi.nlm.nih.gov/16715098","citation_count":287,"is_preprint":false},{"pmid":"23737756","id":"PMC_23737756","title":"GLIS3, a susceptibility gene for type 1 and type 2 diabetes, modulates pancreatic beta cell apoptosis via regulation of a splice variant of the BH3-only protein Bim.","date":"2013","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/23737756","citation_count":144,"is_preprint":false},{"pmid":"14500813","id":"PMC_14500813","title":"GLIS3, a novel member of the GLIS subfamily of Krüppel-like zinc finger proteins with repressor and activation functions.","date":"2003","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/14500813","citation_count":107,"is_preprint":false},{"pmid":"19273592","id":"PMC_19273592","title":"Glis3 is associated with primary cilia and Wwtr1/TAZ and implicated in polycystic kidney disease.","date":"2009","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/19273592","citation_count":88,"is_preprint":false},{"pmid":"20419449","id":"PMC_20419449","title":"Variants at DGKB/TMEM195, ADRA2A, GLIS3 and C2CD4B loci are associated with reduced glucose-stimulated beta cell function in middle-aged Danish people.","date":"2010","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/20419449","citation_count":82,"is_preprint":false},{"pmid":"19264802","id":"PMC_19264802","title":"The Krüppel-like zinc finger protein Glis3 directly and indirectly activates insulin gene transcription.","date":"2009","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/19264802","citation_count":73,"is_preprint":false},{"pmid":"21139041","id":"PMC_21139041","title":"Novel GLIS3 mutations demonstrate an extended multisystem phenotype.","date":"2010","source":"European journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/21139041","citation_count":73,"is_preprint":false},{"pmid":"19481545","id":"PMC_19481545","title":"A murine model of neonatal diabetes mellitus in Glis3-deficient mice.","date":"2009","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/19481545","citation_count":72,"is_preprint":false},{"pmid":"29083325","id":"PMC_29083325","title":"GLIS3 is indispensable for TSH/TSHR-dependent thyroid hormone biosynthesis and follicular cell proliferation.","date":"2017","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/29083325","citation_count":62,"is_preprint":false},{"pmid":"18263616","id":"PMC_18263616","title":"Functional analysis of the zinc finger and activation domains of Glis3 and mutant Glis3(NDH1).","date":"2008","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/18263616","citation_count":61,"is_preprint":false},{"pmid":"26259131","id":"PMC_26259131","title":"Expanding the Clinical Spectrum Associated With GLIS3 Mutations.","date":"2015","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/26259131","citation_count":59,"is_preprint":false},{"pmid":"23197416","id":"PMC_23197416","title":"Sustained expression of the transcription factor GLIS3 is required for normal beta cell function in adults.","date":"2012","source":"EMBO molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/23197416","citation_count":54,"is_preprint":false},{"pmid":"29992946","id":"PMC_29992946","title":"Discovery of a drug candidate for GLIS3-associated diabetes.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29992946","citation_count":54,"is_preprint":false},{"pmid":"21747906","id":"PMC_21747906","title":"Variants in GLIS3 and CRY2 are associated with type 2 diabetes and impaired fasting glucose in Chinese Hans.","date":"2011","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21747906","citation_count":52,"is_preprint":false},{"pmid":"23927931","id":"PMC_23927931","title":"The Krüppel-like protein Gli-similar 3 (Glis3) functions as a key regulator of insulin transcription.","date":"2013","source":"Molecular endocrinology (Baltimore, Md.)","url":"https://pubmed.ncbi.nlm.nih.gov/23927931","citation_count":47,"is_preprint":false},{"pmid":"27899417","id":"PMC_27899417","title":"Emerging roles of GLIS3 in neonatal diabetes, type 1 and type 2 diabetes.","date":"2016","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27899417","citation_count":46,"is_preprint":false},{"pmid":"21786021","id":"PMC_21786021","title":"The Krüppel-like zinc finger protein GLIS3 transactivates neurogenin 3 for proper fetal pancreatic islet differentiation in mice.","date":"2011","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/21786021","citation_count":44,"is_preprint":false},{"pmid":"32693112","id":"PMC_32693112","title":"Transcription factor GLIS3: Critical roles in thyroid hormone biosynthesis, hypothyroidism, pancreatic beta cells and diabetes.","date":"2020","source":"Pharmacology & therapeutics","url":"https://pubmed.ncbi.nlm.nih.gov/32693112","citation_count":35,"is_preprint":false},{"pmid":"27270601","id":"PMC_27270601","title":"The Spatiotemporal Pattern of Glis3 Expression Indicates a Regulatory Function in Bipotent and Endocrine Progenitors during Early Pancreatic Development and in Beta, PP and Ductal Cells.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27270601","citation_count":34,"is_preprint":false},{"pmid":"28648506","id":"PMC_28648506","title":"The role of GLIS3 in thyroid disease as part of a multisystem disorder.","date":"2017","source":"Best practice & research. Clinical endocrinology & metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/28648506","citation_count":33,"is_preprint":false},{"pmid":"17488195","id":"PMC_17488195","title":"Krüppel-like zinc finger protein Glis3 promotes osteoblast differentiation by regulating FGF18 expression.","date":"2007","source":"Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research","url":"https://pubmed.ncbi.nlm.nih.gov/17488195","citation_count":32,"is_preprint":false},{"pmid":"22820919","id":"PMC_22820919","title":"Glis3 regulates neurogenin 3 expression in pancreatic β-cells and interacts with its activator, Hnf6.","date":"2012","source":"Molecules and cells","url":"https://pubmed.ncbi.nlm.nih.gov/22820919","citation_count":32,"is_preprint":false},{"pmid":"31273314","id":"PMC_31273314","title":"PAX8-GLIS3 gene fusion is a pathognomonic genetic alteration of hyalinizing trabecular tumors of the thyroid.","date":"2019","source":"Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc","url":"https://pubmed.ncbi.nlm.nih.gov/31273314","citation_count":31,"is_preprint":false},{"pmid":"27350140","id":"PMC_27350140","title":"Transcription Factor GLIS3: A New and Critical Regulator of Postnatal Stages of Mouse Spermatogenesis.","date":"2016","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/27350140","citation_count":30,"is_preprint":false},{"pmid":"29436472","id":"PMC_29436472","title":"A novel variant in GLIS3 is associated with osteoarthritis.","date":"2018","source":"Annals of the rheumatic diseases","url":"https://pubmed.ncbi.nlm.nih.gov/29436472","citation_count":29,"is_preprint":false},{"pmid":"31340201","id":"PMC_31340201","title":"GLIS3 binds pancreatic beta cell regulatory regions alongside other islet transcription factors.","date":"2019","source":"The Journal of endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/31340201","citation_count":28,"is_preprint":false},{"pmid":"21543335","id":"PMC_21543335","title":"Modulation of the transactivation function and stability of Krüppel-like zinc finger protein Gli-similar 3 (Glis3) by Suppressor of Fused.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21543335","citation_count":27,"is_preprint":false},{"pmid":"29858052","id":"PMC_29858052","title":"Cryptotanshinone Protects Cartilage against Developing Osteoarthritis through the miR-106a-5p/GLIS3 Axis.","date":"2018","source":"Molecular therapy. Nucleic acids","url":"https://pubmed.ncbi.nlm.nih.gov/29858052","citation_count":26,"is_preprint":false},{"pmid":"26147758","id":"PMC_26147758","title":"HECT E3 Ubiquitin Ligase Itch Functions as a Novel Negative Regulator of Gli-Similar 3 (Glis3) Transcriptional Activity.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/26147758","citation_count":25,"is_preprint":false},{"pmid":"28911974","id":"PMC_28911974","title":"Molecular genetics of the transcription factor GLIS3 identifies its dual function in beta cells and neurons.","date":"2017","source":"Genomics","url":"https://pubmed.ncbi.nlm.nih.gov/28911974","citation_count":25,"is_preprint":false},{"pmid":"19609364","id":"PMC_19609364","title":"Polycystic kidney disease in the medaka (Oryzias latipes) pc mutant caused by a mutation in the Gli-Similar3 (glis3) gene.","date":"2009","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/19609364","citation_count":23,"is_preprint":false},{"pmid":"25133201","id":"PMC_25133201","title":"TRANSCRIPTION FACTOR GLI-SIMILAR 3 (GLIS3): IMPLICATIONS FOR THE DEVELOPMENT OF CONGENITAL HYPOTHYROIDISM.","date":"2014","source":"Journal of endocrinology, diabetes & obesity","url":"https://pubmed.ncbi.nlm.nih.gov/25133201","citation_count":23,"is_preprint":false},{"pmid":"30376208","id":"PMC_30376208","title":"GLIS3 Transcriptionally Activates WNT Genes to Promote Differentiation of Human Embryonic Stem Cells into Posterior Neural Progenitors.","date":"2018","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/30376208","citation_count":22,"is_preprint":false},{"pmid":"34762494","id":"PMC_34762494","title":"Exosome-Mediated Transfer of circ-GLIS3 Enhances Temozolomide Resistance in Glioma Cells Through the miR-548m/MED31 Axis.","date":"2021","source":"Cancer biotherapy & radiopharmaceuticals","url":"https://pubmed.ncbi.nlm.nih.gov/34762494","citation_count":20,"is_preprint":false},{"pmid":"28253873","id":"PMC_28253873","title":"Extended clinical features associated with novel Glis3 mutation: a case report.","date":"2017","source":"BMC endocrine disorders","url":"https://pubmed.ncbi.nlm.nih.gov/28253873","citation_count":20,"is_preprint":false},{"pmid":"27148679","id":"PMC_27148679","title":"An emerging, recognizable facial phenotype in association with mutations in GLI-similar 3 (GLIS3).","date":"2016","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/27148679","citation_count":19,"is_preprint":false},{"pmid":"34943978","id":"PMC_34943978","title":"GLIS3: A Critical Transcription Factor in Islet β-Cell Generation.","date":"2021","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/34943978","citation_count":18,"is_preprint":false},{"pmid":"29146476","id":"PMC_29146476","title":"Mutation screening of the GLIS3 gene in a cohort of 592 Chinese patients with congenital hypothyroidism.","date":"2017","source":"Clinica chimica acta; international journal of clinical chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/29146476","citation_count":17,"is_preprint":false},{"pmid":"34093443","id":"PMC_34093443","title":"Case Report: Neonatal Diabetes Mellitus Caused by a Novel GLIS3 Mutation in Twins.","date":"2021","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/34093443","citation_count":17,"is_preprint":false},{"pmid":"23856252","id":"PMC_23856252","title":"A low-frequency GLIS3 variant associated with resistance to Japanese type 1 diabetes.","date":"2013","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/23856252","citation_count":17,"is_preprint":false},{"pmid":"27813676","id":"PMC_27813676","title":"Differential Gene Dosage Effects of Diabetes-Associated Gene GLIS3 in Pancreatic β Cell Differentiation and Function.","date":"2017","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/27813676","citation_count":17,"is_preprint":false},{"pmid":"35093813","id":"PMC_35093813","title":"GLIS3 mediated by the Rap1/PI3K/AKT signal pathway facilitates real-ambient PM2.5 exposure disturbed thyroid hormone homeostasis regulation.","date":"2022","source":"Ecotoxicology and environmental safety","url":"https://pubmed.ncbi.nlm.nih.gov/35093813","citation_count":15,"is_preprint":false},{"pmid":"28597135","id":"PMC_28597135","title":"GLIS3 rs7020673 and rs10758593 polymorphisms interact in the susceptibility for type 1 diabetes mellitus.","date":"2017","source":"Acta diabetologica","url":"https://pubmed.ncbi.nlm.nih.gov/28597135","citation_count":15,"is_preprint":false},{"pmid":"30555422","id":"PMC_30555422","title":"GLIS3 and Thyroid: A Pleiotropic Candidate Gene for Congenital Hypothyroidism.","date":"2018","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30555422","citation_count":13,"is_preprint":false},{"pmid":"36114444","id":"PMC_36114444","title":"A circular RNA derived from GLIS3 accelerates the proliferation of glioblastoma cells through competitively binding with miR-449c-5p to upregulate CAPG and GLIS3.","date":"2022","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/36114444","citation_count":13,"is_preprint":false},{"pmid":"36793061","id":"PMC_36793061","title":"GLIS3 regulates transcription of thyroid hormone biosynthetic genes in coordination with other thyroid transcription factors.","date":"2023","source":"Cell & bioscience","url":"https://pubmed.ncbi.nlm.nih.gov/36793061","citation_count":13,"is_preprint":false},{"pmid":"32383186","id":"PMC_32383186","title":"Oncogenic properties and signaling basis of the PAX8-GLIS3 fusion gene.","date":"2020","source":"International journal of cancer","url":"https://pubmed.ncbi.nlm.nih.gov/32383186","citation_count":12,"is_preprint":false},{"pmid":"35410112","id":"PMC_35410112","title":"Neonatal Diabetes, Congenital Hypothyroidism, and Congenital Glaucoma Coexistence: A Case of GLIS3 Mutation.","date":"2022","source":"Journal of clinical research in pediatric endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/35410112","citation_count":12,"is_preprint":false},{"pmid":"31797737","id":"PMC_31797737","title":"Glis3 as a Critical Regulator of Thyroid Primordium Specification.","date":"2020","source":"Thyroid : official journal of the American Thyroid Association","url":"https://pubmed.ncbi.nlm.nih.gov/31797737","citation_count":12,"is_preprint":false},{"pmid":"30094379","id":"PMC_30094379","title":"PIAS-family proteins negatively regulate Glis3 transactivation function through SUMO modification in pancreatic β cells.","date":"2018","source":"Heliyon","url":"https://pubmed.ncbi.nlm.nih.gov/30094379","citation_count":10,"is_preprint":false},{"pmid":"25810360","id":"PMC_25810360","title":"4D MRI of polycystic kidneys from rapamycin-treated Glis3-deficient mice.","date":"2015","source":"NMR in biomedicine","url":"https://pubmed.ncbi.nlm.nih.gov/25810360","citation_count":9,"is_preprint":false},{"pmid":"39505148","id":"PMC_39505148","title":"GLIS3: A novel transcriptional regulator of mitochondrial functions and metabolic reprogramming in postnatal kidney and polycystic kidney disease.","date":"2024","source":"Molecular metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/39505148","citation_count":9,"is_preprint":false},{"pmid":"35394098","id":"PMC_35394098","title":"Case report: Neonatal diabetes mellitus with congenital hypothyroidism as a result of biallelic heterozygous mutations in GLIS3 gene.","date":"2022","source":"Pediatric diabetes","url":"https://pubmed.ncbi.nlm.nih.gov/35394098","citation_count":9,"is_preprint":false},{"pmid":"28523428","id":"PMC_28523428","title":"The Potential Role of Krüppel-Like Zinc-Finger Protein Glis3 in Genetic Diseases and Cancers.","date":"2017","source":"Archivum immunologiae et therapiae experimentalis","url":"https://pubmed.ncbi.nlm.nih.gov/28523428","citation_count":8,"is_preprint":false},{"pmid":"33667596","id":"PMC_33667596","title":"Molecular and clinical genetics of the transcription factor GLIS3 in Chinese congenital hypothyroidism.","date":"2021","source":"Molecular and cellular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/33667596","citation_count":6,"is_preprint":false},{"pmid":"32668405","id":"PMC_32668405","title":"Identification of a novel lncRNA (G3R1) regulated by GLIS3 in pancreatic β-cells.","date":"2020","source":"Journal of molecular endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32668405","citation_count":6,"is_preprint":false},{"pmid":"31533988","id":"PMC_31533988","title":"A GLIS3-CD133-WNT-signaling axis regulates the self-renewal of adult murine pancreatic progenitor-like cells in colonies and organoids.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31533988","citation_count":6,"is_preprint":false},{"pmid":"38226164","id":"PMC_38226164","title":"circGlis3 promotes β-cell dysfunction by binding to heterogeneous nuclear ribonucleoprotein F and encoding Glis3-348aa protein.","date":"2023","source":"iScience","url":"https://pubmed.ncbi.nlm.nih.gov/38226164","citation_count":6,"is_preprint":false},{"pmid":"38051360","id":"PMC_38051360","title":"Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas.","date":"2023","source":"Diabetologia","url":"https://pubmed.ncbi.nlm.nih.gov/38051360","citation_count":5,"is_preprint":false},{"pmid":"32681364","id":"PMC_32681364","title":"Association study of the functional variants of the GLIS3 gene with risk of knee osteoarthritis.","date":"2020","source":"Clinical rheumatology","url":"https://pubmed.ncbi.nlm.nih.gov/32681364","citation_count":5,"is_preprint":false},{"pmid":"29606121","id":"PMC_29606121","title":"Polymorphism of the GLIS3 gene in a Caucasian population and among individuals with carbohydrate metabolism disorders in Russia.","date":"2018","source":"BMC research notes","url":"https://pubmed.ncbi.nlm.nih.gov/29606121","citation_count":5,"is_preprint":false},{"pmid":"38888423","id":"PMC_38888423","title":"Variations in the LINGO2 and GLIS3 Genes and Gene-Environment Interactions Increase Gestational Diabetes Mellitus Risk in Chinese Women.","date":"2024","source":"Environmental science & technology","url":"https://pubmed.ncbi.nlm.nih.gov/38888423","citation_count":5,"is_preprint":false},{"pmid":"29941866","id":"PMC_29941866","title":"Loss of Glis3 causes dysregulation of retrotransposon silencing and germ cell demise in fetal mouse testis.","date":"2018","source":"Scientific reports","url":"https://pubmed.ncbi.nlm.nih.gov/29941866","citation_count":4,"is_preprint":false},{"pmid":"35927023","id":"PMC_35927023","title":"Detection of a GLIS3 fusion in an infant with AML refractory to chemotherapy.","date":"2022","source":"Cold Spring Harbor molecular case studies","url":"https://pubmed.ncbi.nlm.nih.gov/35927023","citation_count":4,"is_preprint":false},{"pmid":"38705974","id":"PMC_38705974","title":"A case of hyalinizing trabecular tumor of the thyroid: diagnostic significance of PAX8-GLIS3 fusion.","date":"2024","source":"Thyroid research","url":"https://pubmed.ncbi.nlm.nih.gov/38705974","citation_count":4,"is_preprint":false},{"pmid":"41501466","id":"PMC_41501466","title":"Bidirectional CRISPR screens decode a GLIS3-dependent fibrotic cell circuit.","date":"2026","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/41501466","citation_count":2,"is_preprint":false},{"pmid":"39304594","id":"PMC_39304594","title":"FAM83H regulated by glis3 promotes triple-negative breast cancer tumorigenesis and activates the NF-κB signaling pathway.","date":"2024","source":"Journal of molecular histology","url":"https://pubmed.ncbi.nlm.nih.gov/39304594","citation_count":2,"is_preprint":false},{"pmid":"40583116","id":"PMC_40583116","title":"Congenital glaucoma associated with high hyperopia, an ophthalmic phenotypical manifestation for GLIS3 deletion: case report and review of literature.","date":"2025","source":"Ophthalmic genetics","url":"https://pubmed.ncbi.nlm.nih.gov/40583116","citation_count":2,"is_preprint":false},{"pmid":"22555020","id":"PMC_22555020","title":"Expression pattern of a single transgene cassette located in endogenous GLIS3 of cloned pigs; a nested situation.","date":"2012","source":"Gene","url":"https://pubmed.ncbi.nlm.nih.gov/22555020","citation_count":2,"is_preprint":false},{"pmid":"36917836","id":"PMC_36917836","title":"Liver Disease in GLIS3 Mutations: Transplant Considerations and Bile Duct Paucity on Explant Histology.","date":"2023","source":"Journal of pediatric gastroenterology and nutrition","url":"https://pubmed.ncbi.nlm.nih.gov/36917836","citation_count":1,"is_preprint":false},{"pmid":"38652652","id":"PMC_38652652","title":"Downregulation of Glis3 in INS1 cells exposed to chronically elevated glucose contributes to glucotoxicity-associated β cell dysfunction.","date":"2024","source":"Islets","url":"https://pubmed.ncbi.nlm.nih.gov/38652652","citation_count":1,"is_preprint":false},{"pmid":"41563804","id":"PMC_41563804","title":"Glis3 Is a Modifier of Cyst Progression in Autosomal Dominant Polycystic Kidney Disease.","date":"2025","source":"Journal of the American Society of Nephrology : JASN","url":"https://pubmed.ncbi.nlm.nih.gov/41563804","citation_count":1,"is_preprint":false},{"pmid":"28846454","id":"PMC_28846454","title":"GLIS3 and TYK2 Single Nucleotide Polymorphisms Are Not Associated with Dermatomyositis/Polymyositis in Chinese Han Population.","date":"2017","source":"Genetic testing and molecular biomarkers","url":"https://pubmed.ncbi.nlm.nih.gov/28846454","citation_count":1,"is_preprint":false},{"pmid":"41826646","id":"PMC_41826646","title":"Regulation of PKM2 expression and function by GLIS3 during metabolic reprogramming in polycystic kidneys.","date":"2026","source":"Experimental & molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41826646","citation_count":0,"is_preprint":false},{"pmid":"41457180","id":"PMC_41457180","title":"Glis3 as a critical regulator of Pit1-lineages and renal functions.","date":"2025","source":"Journal of molecular medicine (Berlin, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/41457180","citation_count":0,"is_preprint":false},{"pmid":"41369402","id":"PMC_41369402","title":"Alternative Splicing (AS) Provides an Alternative Mechanism for Regulating GLIS3 Expression and Activity.","date":"2025","source":"Cells","url":"https://pubmed.ncbi.nlm.nih.gov/41369402","citation_count":0,"is_preprint":false},{"pmid":"36206155","id":"PMC_36206155","title":"Gli-similar 3 (GLIS3) rs7020763 (C>G) polymorphism in patients with type 2 diabetes mellitus.","date":"2022","source":"The Egyptian journal of immunology","url":"https://pubmed.ncbi.nlm.nih.gov/36206155","citation_count":0,"is_preprint":false},{"pmid":"42024906","id":"PMC_42024906","title":"Association of GCKR and GLIS3 gene polymorphisms with gestational diabetes mellitus: A case-control study.","date":"2026","source":"The Indian journal of medical research","url":"https://pubmed.ncbi.nlm.nih.gov/42024906","citation_count":0,"is_preprint":false},{"pmid":"40661540","id":"PMC_40661540","title":"Glis3 is a modifier of cyst progression in autosomal dominant polycystic kidney disease.","date":"2025","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/40661540","citation_count":0,"is_preprint":false},{"pmid":"40122401","id":"PMC_40122401","title":"Hyalinizing trabecular tumor of the thyroid: Interest of GLIS3 immunohistochemical study to detect PAX8::GLIS3 rearrangement.","date":"2025","source":"Human pathology","url":"https://pubmed.ncbi.nlm.nih.gov/40122401","citation_count":0,"is_preprint":false},{"pmid":"41542538","id":"PMC_41542538","title":"Identification of distinct functions of GLIS3 in β-cell generation critical to prevention of neonatal diabetes.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41542538","citation_count":0,"is_preprint":false},{"pmid":"41778042","id":"PMC_41778042","title":"Case Report: Membranous/cytoplasmic Ki-67 staining and PAX8-GLIS3 fusion: defining the clinicopathological spectrum of hyalinizing trabecular tumor to optimize patient management.","date":"2026","source":"Frontiers in medicine","url":"https://pubmed.ncbi.nlm.nih.gov/41778042","citation_count":0,"is_preprint":false},{"pmid":"41959138","id":"PMC_41959138","title":"GLIS3 is a key regulator of astrocyte differentiation in human neural stem cells.","date":"2026","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/41959138","citation_count":0,"is_preprint":false},{"pmid":"41272565","id":"PMC_41272565","title":"GLIS3 rs7034200 and ADRB3 rs4994 genetic variants associated with an increased risk of gestational diabetes mellitus in Chinese women: a case-control study.","date":"2025","source":"BMC pregnancy and childbirth","url":"https://pubmed.ncbi.nlm.nih.gov/41272565","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.09.18.677140","title":"GLIS3 Marks a Neural-like Progenitor Cell State that Drives Metastasis in Pancreatic Ductal Adenocarcinoma","date":"2025-09-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.18.677140","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.03.28.25324850","title":"Whole-Genome Sequencing Reveals Individual and Cohort Level Insights into Chromosome 9p Syndromes","date":"2025-03-30","source":"bioRxiv","url":"https://doi.org/10.1101/2025.03.28.25324850","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":45133,"output_tokens":7877,"usd":0.126777},"stage2":{"model":"claude-opus-4-6","input_tokens":11633,"output_tokens":4286,"usd":0.247973},"total_usd":0.37475,"stage1_batch_id":"msgbatch_01DzrsgVgYngY1hvM3DU1yF2","stage2_batch_id":"msgbatch_01KA9b7iRzKFdhoBUT7vCvSe","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2003,\n      \"finding\": \"GLIS3 is an 83.8 kDa nuclear protein containing five C2H2-type Krüppel-like zinc finger motifs that can function as both a repressor and activator of transcription; it binds the GLI-RE consensus sequence and enhances GLI-RE-dependent transcription; deletion mutant analysis showed the N- and C-termini are required for optimal transcriptional activity.\",\n      \"method\": \"Reporter assays, deletion mutant analysis, DNA-binding assays, whole-mount in situ hybridization\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — multiple in vitro assays and mutagenesis in original characterization paper\",\n      \"pmids\": [\"14500813\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"Loss-of-function mutations in GLIS3 (frameshift and large deletions) cause neonatal diabetes and congenital hypothyroidism; GLIS3 is expressed preferentially in pancreatic beta cells and thyroid from early developmental stages, establishing its role in beta cell and thyroid development.\",\n      \"method\": \"Human genetic mutation identification, gene expression analysis (tissue-specific transcripts)\",\n      \"journal\": \"Nature genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human loss-of-function mutations with defined organ-specific phenotypes, multiple families\",\n      \"pmids\": [\"16715098\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"The fourth zinc finger tetrahedral configuration is essential for nuclear localization of GLIS3 (not the putative bipartite NLS); all five zinc finger motifs are critical for efficient DNA binding; the consensus high-affinity Glis3 DNA-binding site is (G/C)TGGGGGGT(A/C); the C-terminus contains the transactivation domain; the NDH1 frameshift mutation truncates the C-terminus, abolishing transactivating activity without affecting nuclear localization.\",\n      \"method\": \"Deletion mutant analysis, EMSA (electrophoretic mobility shift assay), reporter transcription assays, mutagenesis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro binding assays, mutagenesis, and functional reporter assays with multiple mutants\",\n      \"pmids\": [\"18263616\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"GLIS3 localizes to the primary cilium as well as the nucleus; GLIS3 interacts with the transcriptional coactivator Wwtr1/TAZ via a P/LPXY motif in the GLIS3 C-terminus; Wwtr1 enhances GLIS3-mediated transcriptional activation; mutations in the P/LPXY motif abrogate both Wwtr1 interaction and transcriptional activity; Glis3-deficient mice develop polycystic kidney disease.\",\n      \"method\": \"Co-immunoprecipitation, subcellular localization (confocal imaging), reporter assays, mutagenesis, mouse knockout model\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — reciprocal co-IP, mutagenesis, direct localization, and functional transcription assays\",\n      \"pmids\": [\"19273592\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Glis3 directly binds the insulin 2 (Ins2) promoter at a Glis3 response element (5'-GTCCCCTGCTGTGAA-3', positions -255 to -241) via its zinc finger region; Glis3 physically and functionally interacts with Pdx1, MafA, and NeuroD1 to modulate Ins2 promoter activity; Glis3 also upregulates MafA and downregulates Nkx6-1.\",\n      \"method\": \"Chromatin immunoprecipitation (ChIP), EMSA, reporter/deletion assays, co-immunoprecipitation, siRNA knockdown\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP, EMSA, and functional reporter assays with multiple orthogonal methods\",\n      \"pmids\": [\"19264802\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Glis3-deficient mice exhibit neonatal diabetes due to impaired islet development and decreased insulin mRNA, establishing GLIS3 as essential for insulin-producing cell formation in vivo.\",\n      \"method\": \"Gene-targeted knockout mouse, blood glucose measurement, insulin mRNA quantification, histology\",\n      \"journal\": \"FEBS letters\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean KO with defined cellular phenotype, corroborated by additional KO papers\",\n      \"pmids\": [\"19481545\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"GLIS3 directly binds specific GLIS3-response elements in the Neurogenin 3 (Neurog3/Ngn3) promoter and activates Neurog3 transcription; GLIS3 acts synergistically with Hnf6 and FoxA2 to activate Ngn3, placing GLIS3 upstream of Neurog3 in the endocrine pancreas differentiation hierarchy.\",\n      \"method\": \"In vivo genetic analysis (Glis3-/- mouse), ChIP, promoter reporter assays, epistasis, in vitro reconstitution\",\n      \"journal\": \"Diabetologia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP, reporter assays, and in vivo epistasis across multiple methods\",\n      \"pmids\": [\"21786021\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"SUFU interacts with GLIS3 through a VYGHF motif in the conserved N-terminal region of GLIS3; SUFU inhibits GLIS3-mediated insulin promoter activation in a binding-dependent manner; SUFU promotes nuclear accumulation of itself when GLIS3 is present; SUFU stabilizes GLIS3 by antagonizing a Cullin 3-based E3 ubiquitin ligase that ubiquitinates and degrades GLIS3.\",\n      \"method\": \"Co-immunoprecipitation, reporter assays, mutagenesis, ubiquitination assays, subcellular localization\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — multiple orthogonal methods including co-IP, ubiquitination assay, and functional reporter assays\",\n      \"pmids\": [\"21543335\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"GLIS3 promotes osteoblast differentiation in multipotent C3H10T1/2 cells, acts synergistically with BMP2 and Shh, and induces FGF18 expression via a Glis3 binding site in the FGF18 promoter flanking region; the C-terminal activation function is required for this effect.\",\n      \"method\": \"Microarray, reporter assays, EMSA, alkaline phosphatase activity, siRNA/overexpression\",\n      \"journal\": \"Journal of bone and mineral research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — EMSA and reporter assays with functional cellular readout, single lab\",\n      \"pmids\": [\"17488195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Glis3 directly interacts with Hnf6 in vitro and in vivo; the Glis3 N-terminus and the Hnf6 homeodomain are required for this interaction; both proteins cooperatively activate Ngn3 transcription through the distal Ngn3 promoter region.\",\n      \"method\": \"Co-immunoprecipitation, in vitro binding assay, ChIP, reporter assays, deletion/mutagenesis\",\n      \"journal\": \"Molecules and cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro and in vivo binding assays plus functional ChIP and reporter assays\",\n      \"pmids\": [\"22820919\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Sustained GLIS3 expression in adult beta cells is required for insulin expression and beta cell mass maintenance; GLIS3 controls beta cell proliferation in response to high-fat diet by regulating Ccnd2 (Cyclin D2) transcription.\",\n      \"method\": \"Conditional knockout mouse (Glis3fl/fl/Pdx1CreERT+), tamoxifen induction, glucose tolerance testing, gene expression analysis\",\n      \"journal\": \"EMBO molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — conditional KO with defined cellular phenotype and molecular mechanism\",\n      \"pmids\": [\"23197416\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GLIS3 knockdown increases beta cell apoptosis via the intrinsic (mitochondrial) pathway (cytochrome c release, Bax translocation, caspase 9/3 activation); GLIS3 loss promotes alternative splicing of the pro-apoptotic BH3-only protein Bim, favouring the pro-death variant BimS via inhibition of the splicing factor SRp55; KD of Bim abrogates the pro-apoptotic effect of GLIS3 loss.\",\n      \"method\": \"siRNA knockdown in INS-1E cells, primary rat beta cells and human islets; cytochrome c fractionation; Bax translocation; caspase activity assays; RT-PCR for splice variants\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple cell models, orthogonal apoptosis readouts, and rescue experiment with Bim KD\",\n      \"pmids\": [\"23737756\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"GLIS3 binding to GlisBS in the insulin promoter is required as a scaffold for the stable association of Pdx1, NeuroD1, and MafA with the insulin promoter; GLIS3 recruits CBP/p300 to form a larger transcriptional regulatory complex; GlisBS mutation prevents stable Pdx1 and MafA binding and reduces insulin promoter activation by all three factors.\",\n      \"method\": \"ChIP, reporter assays, siRNA knockdown, GlisBS mutagenesis, co-immunoprecipitation\",\n      \"journal\": \"Molecular endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP with mutant promoter, co-IP, and functional reporter assays demonstrating scaffold mechanism\",\n      \"pmids\": [\"23927931\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"The HECT E3 ubiquitin ligase Itch interacts with GLIS3 through WW domain–PPxY motif interaction in the GLIS3 N-terminus, polyubiquitinates GLIS3, and enhances its proteasomal degradation, thereby inhibiting GLIS3-mediated transactivation and endogenous Ins2 expression; Itch-mediated degradation requires both the PPxY motif and GLIS3 zinc finger domains.\",\n      \"method\": \"Mass spectrometry, yeast 2-hybrid, co-immunoprecipitation, ubiquitination assays, proteasome inhibitor experiments, reporter assays, mutagenesis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — mass spectrometry, co-IP, ubiquitination assay, and functional reporter assays with multiple mutants\",\n      \"pmids\": [\"26147758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Glis3 is expressed in bipotent progenitors in the trunk domain (co-localizing with Sox9, Hnf6, Pdx1), in Ngn3+ endocrine progenitors, and in mature beta, PP, and ductal cells (but not in multipotent tip progenitors); Glis3-deficiency reduces and exogenous Glis3 induces Ppy (pancreatic polypeptide) expression.\",\n      \"method\": \"Glis3-EGFP knockin mouse, immunohistochemistry, live imaging, co-localization analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization via knockin reporter with functional consequence\",\n      \"pmids\": [\"27270601\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"GLIS3 is expressed in gonocytes, spermatogonial stem cells (SSCs), and spermatogonial progenitors; loss of GLIS3 impairs gonocyte-to-SSC transition and inhibits cytoplasmic-to-nuclear translocation of FOXO1 (a marker of gonocyte-to-SSC transition required for SSC self-renewal).\",\n      \"method\": \"GLIS3 knockout mice, gene expression profiling, immunohistochemistry, FOXO1 localization assay\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with defined cellular phenotype and mechanistic link to FOXO1 localization\",\n      \"pmids\": [\"27350140\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"GLIS3 acts downstream of TSH/TSHR signaling and is indispensable for TSH/TSHR-mediated thyroid follicular cell proliferation and thyroid hormone biosynthesis; ChIP-Seq showed GLIS3 directly binds and activates promoters of Nis (Slc5a5) and Pds (Slc26a4) iodide transporters; GLIS3 deficiency inhibits mTORC1/RPS6 pathway activation downstream of TSH, suppressing cell division.\",\n      \"method\": \"GLIS3-deficient mouse model, ChIP-Seq, promoter analysis, mTORC1/RPS6 signaling assays, proliferation assays\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-Seq, pathway analysis, and in vivo KO with defined cellular phenotype\",\n      \"pmids\": [\"29083325\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"SUMO modification of GLIS3 at two conserved lysine residues in the N-terminus, mediated by PIASy and Ubc9, dramatically inhibits GLIS3-mediated insulin transcription; SUMOylation of GLIS3 is increased under chronically elevated glucose conditions and correlates with decreased insulin transcription.\",\n      \"method\": \"SUMOylation assays, reporter assays, mutagenesis of lysine residues, glucose treatment experiments\",\n      \"journal\": \"Heliyon\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro SUMO modification with mutagenesis and functional reporter assay, single lab\",\n      \"pmids\": [\"30094379\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"GLIS3 directly activates WNT gene transcription (including WNT3A) in human embryonic stem cells, driving their differentiation toward posterior neural progenitor cells; inhibition of WNT signaling abrogates GLIS3-induced posterior specification.\",\n      \"method\": \"RNA-Seq, ChIP-Seq, functional reporter assays, WNT inhibition rescue experiments, hESC differentiation\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-Seq, RNA-Seq, and pharmacological rescue experiment with orthogonal methods\",\n      \"pmids\": [\"30376208\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of GLIS3 in hESC-derived pancreatic progenitors causes beta-cell death by activating the TGFβ pathway; a drug screen identified a compound that rescues GLIS3-/- associated beta-cell death in vitro and in vivo.\",\n      \"method\": \"GLIS3-/- hESC directed differentiation, high-content chemical screen, TGFβ pathway analysis, in vivo xenograft\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human stem cell KO with pathway identification and in vivo rescue\",\n      \"pmids\": [\"29992946\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GLIS3 binds pancreatic beta cell regulatory regions that coincide with binding sites for other islet-enriched transcription factors; ChIP-Seq combined with RNA-Seq revealed direct regulation of Slc2a2 (Glut2) and Mafa by GLIS3 in addition to Ins2 and Ngn3; loss of GLIS3 in beta cells produces PDX1+/INS-/MAFA-/GLUT2- cells without increased cell death.\",\n      \"method\": \"Pancreas-specific Glis3 conditional KO, GLIS3 ChIP-Seq, islet RNA-Seq, immunohistochemistry\",\n      \"journal\": \"The Journal of endocrinology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-Seq and RNA-Seq with conditional KO mouse model\",\n      \"pmids\": [\"31340201\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"GLIS3 is required for self-renewal of adult murine pancreatic colony-forming units (PCFUs); GLIS3 maintains WNT receptor and signaling molecule expression (a GLIS3-CD133-WNT axis); CD133 (but not GLIS3 or WNT) is required for PI3K/AKT-mediated PCFU survival.\",\n      \"method\": \"shRNA knockdown in sorted CD133highCD71low ductal cells, ex vivo colony/organoid assays, gene expression analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — KD in primary cells with colony assay readout, single lab\",\n      \"pmids\": [\"31533988\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Loss of Glis3 in fetal male germ cells causes widespread reduction in retrotransposon silencing factors and aberrant retrotransposon expression; precocious Glis3 expression in vivo results in premature expression of piRNA pathway members, indicating GLIS3 is necessary for activation of retrotransposon silencing programs.\",\n      \"method\": \"Glis3 KO mouse, gene expression profiling, in vivo transgenic induction of Glis3\",\n      \"journal\": \"Scientific reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KO and gain-of-function in vivo with defined molecular phenotype, single lab\",\n      \"pmids\": [\"29941866\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"GLIS3 co-regulates transcription of thyroid hormone biosynthetic genes (including Slc5a5/Nis, Slc26a4, Cdh16, Adm2) by binding within the same regulatory regions as PAX8, NKX2.1, and FOXE1; loss of GLIS3 does not significantly alter PAX8 or NKX2.1 binding or H3K4me3/H3K27me3 epigenetic marks, suggesting GLIS3 activates transcription by enhancing interactions with enhancers and/or RNA Pol II complexes rather than restructuring chromatin.\",\n      \"method\": \"PAX8/NKX2.1/FOXE1 ChIP-Seq in mouse thyroid and PCCl3 cells, comparison to GLIS3 cistrome, ChIP-QPCR, histone mark analysis in Glis3KO\",\n      \"journal\": \"Cell & bioscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-Seq with multiple TFs and KO mouse, orthogonal epigenomic analysis\",\n      \"pmids\": [\"36793061\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GLIS3 directly regulates genes critical for mitochondrial biogenesis, OXPHOS, fatty acid oxidation, and TCA cycle in kidney (including Tfam, Ppargc1a/b, Hadha, Sdha); GLIS3 ChIP-Seq showed binding near these genes; GLIS3 binding loci frequently co-localize with HNF1B and NRF1; loss of GLIS3 causes metabolic reprogramming toward aerobic glycolysis and glutamine anaplerosis in kidney.\",\n      \"method\": \"Transcriptomics, ChIP-Seq (cistromics), untargeted metabolomics, Seahorse analysis, tissue-specific KO mice\",\n      \"journal\": \"Molecular metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-Seq, metabolomics, and functional Seahorse assay in KO model, multiple orthogonal methods\",\n      \"pmids\": [\"39505148\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"GLIS3 directly represses Pkm (pyruvate kinase M) expression in kidney; loss of GLIS3 elevates PKM2 dimer-promoting phosphorylations (Y105, S37) and increases aerobic glycolysis; pharmacological inhibition of PKM2 in GLIS3-deficient cultures and kidneys reduces cyst growth, linking GLIS3-mediated glycolytic repression to cystogenesis.\",\n      \"method\": \"Transcriptomics, ChIP-Seq, siRNA knockdown, phosphorylation analysis, PKM2 inhibitor treatment, spheroid/cyst assays\",\n      \"journal\": \"Experimental & molecular medicine\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — ChIP-Seq, KO models, pharmacological rescue, and multiple orthogonal readouts\",\n      \"pmids\": [\"41826646\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"In zebrafish, glis3 is required for early thyroid primordium specification; glis3 morphants show reduced nkx2.4 and pax2a expression at the thyroid primordium; glis3 functions as an effector of the Sonic Hedgehog (SHH) pathway in thyroid development; pharmacological SHH inhibition reproduces thyroid defects seen in glis3 morphants.\",\n      \"method\": \"Morpholino knockdown in zebrafish, in situ hybridization, immunohistochemistry, pharmacological SHH inhibition\",\n      \"journal\": \"Thyroid\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — morpholino KD with molecular pathway rescue, zebrafish ortholog\",\n      \"pmids\": [\"31797737\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"The PAX8-GLIS3 fusion oncogene (exons 1-2 of PAX8 fused to exons 3-11 of GLIS3) increases proliferation, clonogenic potential, and migration of thyroid and HEK-293 cells; these oncogenic effects are mediated through activation of the Sonic Hedgehog (SHH) pathway; SMO inhibitor cyclopamine partially reverses these effects.\",\n      \"method\": \"Forced expression in cell lines, proliferation/migration assays, xenograft models, SHH pathway inhibition\",\n      \"journal\": \"International journal of cancer\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — in vitro functional assays, in vivo xenograft, and pharmacological pathway rescue\",\n      \"pmids\": [\"32383186\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"CircGlis3, derived from exon 4 of Glis3, promotes beta-cell dysfunction by: (1) binding hnRNPF and blocking its nuclear translocation, thereby reducing Sirt1 levels; (2) encoding a 348aa protein that interacts with GLIS3 and inhibits its transcriptional activity; CELF1 facilitates biogenesis of circGlis3.\",\n      \"method\": \"Transgenic mouse model, RNA pulldown, protein interaction assays, nuclear fractionation, CRISPR overexpression\",\n      \"journal\": \"iScience\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — in vivo transgenic model and molecular interaction assays, single lab\",\n      \"pmids\": [\"38226164\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Glis3 acts as a pioneer-like factor at the insulin promoter, permissively remodeling chromatin to allow access by Pdx1 and MafA; Glis3 positively regulates MafA transcription through its pancreas-specific promoter; MafA reciprocally regulates Glis3 expression; Glis3 is downregulated by oxidative stress in glucotoxic conditions.\",\n      \"method\": \"CRISPR/Cas9 knockdown, chromatin accessibility assays, reporter assays, gene expression analysis in INS1 cells under high glucose\",\n      \"journal\": \"Islets\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — chromatin remodeling evidence and reciprocal regulation assays, single lab\",\n      \"pmids\": [\"38652652\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"GLIS3 is a key transcriptional regulator of an inflammation-fibrosis cell circuit in intestinal fibroblasts; fibroblast-specific deletion of Glis3 in mice alleviates chronic colitis; GLIS3 governs expression of inflammatory and fibrotic genes in inflammation-associated fibroblasts induced by FCN1+IL1B+ macrophages, which in turn produce profibrotic IL-11.\",\n      \"method\": \"Genome-wide CRISPR knockout and activation screens, fibroblast-specific conditional KO mouse, single-cell and spatial transcriptomics, colitis model\",\n      \"journal\": \"Nature\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — genome-wide CRISPR screens, conditional KO with disease model, and spatial transcriptomics\",\n      \"pmids\": [\"41501466\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Alternative splicing of mouse Glis3 produces a shorter isoform lacking exon 3 (659 aa vs. 935 aa); the shorter isoform is expressed at higher levels in all mouse tissues, is more stable, and exhibits greater transactivation potential; mass spectrometry identified phosphorylation sites and co-activator/co-repressor complex members (including known members) as GLIS3 interactors.\",\n      \"method\": \"RT-PCR, isoform-specific expression analysis, stability assays, reporter assays, mass spectrometry\",\n      \"journal\": \"Cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2–3 — functional isoform comparison with mass spectrometry, single lab\",\n      \"pmids\": [\"41369402\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"GLIS3 is a Krüppel-like zinc finger transcription factor that localizes to both the nucleus and primary cilia; it activates or represses transcription by binding the consensus sequence (G/C)TGGGGGGT(A/C) through all five zinc fingers, with the C-terminus providing transactivation activity that is regulated by post-translational modifications (ubiquitination by Itch/Cullin3-E3, SUMOylation by PIAS/Ubc9) and by interaction with SUFU (which stabilizes GLIS3 against Cullin3-mediated degradation); in pancreatic beta cells GLIS3 serves as a scaffold recruiting CBP/p300, Pdx1, MafA, and NeuroD1 to the insulin promoter for transcriptional activation, directly transactivates Ngn3 (in cooperation with Hnf6 and FoxA2) to drive endocrine progenitor specification, and controls beta cell survival by regulating alternative splicing of pro-apoptotic Bim via SRp55; in thyroid follicular cells GLIS3 acts downstream of TSH/TSHR to activate iodide transporter genes (Nis, Pds) in coordination with PAX8, NKX2.1, and FOXE1, and drives mTORC1-dependent proliferation; in kidney, GLIS3 directly regulates mitochondrial biogenesis, OXPHOS, and fatty acid oxidation genes (in concert with HNF1B and NRF1), and suppresses PKM2-driven aerobic glycolysis, with loss of GLIS3 causing metabolic reprogramming that promotes cystogenesis; and in intestinal fibroblasts GLIS3 regulates an inflammatory-fibrotic gene network downstream of macrophage-derived signals.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"GLIS3 is a Krüppel-like zinc finger transcription factor that functions as a master regulator of pancreatic beta cell development and function, thyroid hormone biosynthesis, renal metabolic homeostasis, and intestinal fibroblast inflammatory programming. It binds the consensus sequence (G/C)TGGGGGGT(A/C) through five C2H2-type zinc fingers, with the C-terminus providing transactivation activity; at the insulin promoter, GLIS3 acts as a scaffold recruiting CBP/p300, Pdx1, MafA, and NeuroD1, and it drives endocrine progenitor specification by directly transactivating Neurogenin 3 in cooperation with Hnf6 and FoxA2 [PMID:14500813, PMID:19264802, PMID:23927931, PMID:21786021]. GLIS3 protein stability and transcriptional output are tuned by ubiquitination (via Itch and Cullin3-based E3 ligases, antagonized by SUFU) and SUMOylation (via PIASy/Ubc9), and in beta cells GLIS3 loss promotes apoptosis through alternative splicing of pro-apoptotic Bim via SRp55 [PMID:21543335, PMID:26147758, PMID:30094379, PMID:23737756]. Loss-of-function mutations in GLIS3 cause neonatal diabetes and congenital hypothyroidism in humans; in thyroid, GLIS3 operates downstream of TSH/TSHR to co-activate iodide transporter genes with PAX8, NKX2.1, and FOXE1, and in kidney it directly controls mitochondrial biogenesis, oxidative phosphorylation, and fatty acid oxidation genes while repressing PKM2-driven aerobic glycolysis, with its loss causing cystogenesis [PMID:16715098, PMID:29083325, PMID:36793061, PMID:39505148, PMID:41826646].\",\n  \"teleology\": [\n    {\n      \"year\": 2003,\n      \"claim\": \"Identification of GLIS3 as a dual-function Krüppel-like zinc finger transcription factor that binds GLI-response elements established the molecular framework for all subsequent functional studies.\",\n      \"evidence\": \"Reporter assays, deletion mutant analysis, DNA-binding assays, and in situ hybridization in the original characterization paper\",\n      \"pmids\": [\"14500813\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No endogenous target genes identified\", \"No in vivo function demonstrated\", \"No post-translational regulation characterized\"]\n    },\n    {\n      \"year\": 2006,\n      \"claim\": \"Discovery that loss-of-function GLIS3 mutations cause neonatal diabetes and congenital hypothyroidism in humans established its essential non-redundant role in beta cell and thyroid development, directing subsequent mechanistic work toward these tissues.\",\n      \"evidence\": \"Identification of frameshift and large deletions in multiple consanguineous families with neonatal diabetes and hypothyroidism\",\n      \"pmids\": [\"16715098\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular targets in beta cells and thyroid unknown\", \"Developmental stage of GLIS3 requirement undefined\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"Mapping of the DNA-binding determinants (all five zinc fingers required, consensus (G/C)TGGGGGGT(A/C)) and localization of the transactivation domain to the C-terminus explained how the human NDH1 frameshift mutation causes disease — by truncating transactivation while preserving nuclear localization.\",\n      \"evidence\": \"EMSA with systematic zinc finger mutants, reporter assays with deletion constructs, analysis of NDH1 mutation\",\n      \"pmids\": [\"18263616\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No genome-wide binding data\", \"No crystal structure of zinc finger–DNA complex\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstration that GLIS3 directly binds the insulin promoter and physically interacts with Pdx1, MafA, and NeuroD1 provided the first mechanistic explanation for how GLIS3 loss causes neonatal diabetes, while concurrent work showed GLIS3 localizes to primary cilia and interacts with Wwtr1/TAZ, linking it to cilia-dependent signaling and polycystic kidney disease.\",\n      \"evidence\": \"ChIP, EMSA, co-IP, reporter assays (insulin promoter); confocal localization to cilia; Glis3 KO mouse developing PKD\",\n      \"pmids\": [\"19264802\", \"19273592\", \"19481545\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GLIS3 acts as a scaffold versus simple activator at the insulin promoter was not resolved\", \"Cilia-to-nucleus signaling mechanism unknown\", \"Wwtr1/TAZ contribution in vivo untested\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"Placing GLIS3 upstream of Neurogenin 3 in the endocrine differentiation hierarchy — via direct promoter binding and synergy with Hnf6 and FoxA2 — and identifying SUFU as a stabilizer that antagonizes Cullin3-mediated GLIS3 degradation revealed both a developmental circuit and a proteostatic control mechanism.\",\n      \"evidence\": \"ChIP and reporter assays on Ngn3 promoter with epistasis in Glis3−/− mice; co-IP, ubiquitination assays, and mutagenesis for SUFU/Cullin3 axis\",\n      \"pmids\": [\"21786021\", \"21543335\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the Cullin3 adaptor for GLIS3 unknown\", \"Whether SUFU regulation occurs in primary cilia unresolved\", \"In vivo significance of SUFU–GLIS3 interaction in beta cells untested\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Conditional deletion in adult beta cells proved that GLIS3 is continuously required — not just developmentally — for insulin expression and beta cell mass maintenance, including proliferative adaptation to metabolic stress via Cyclin D2 regulation.\",\n      \"evidence\": \"Tamoxifen-inducible Glis3 conditional KO in adult mice, glucose tolerance testing, Ccnd2 expression analysis\",\n      \"pmids\": [\"23197416\", \"22820919\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether GLIS3 directly binds the Ccnd2 promoter not shown by ChIP\", \"Mechanism linking GLIS3 loss to proliferative failure beyond Ccnd2 unclear\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Two mechanistic advances resolved how GLIS3 controls beta cell fate: it functions as an obligate scaffold at the insulin promoter (recruiting CBP/p300 for stable Pdx1/MafA association), and its loss triggers beta cell apoptosis through SRp55-mediated alternative splicing of pro-apoptotic Bim — an unexpected splicing-regulatory function.\",\n      \"evidence\": \"GlisBS mutagenesis with ChIP showing loss of Pdx1/MafA binding; Bim splice variant analysis with SRp55 mechanism and Bim-KD rescue in INS-1E, primary rat beta cells, and human islets\",\n      \"pmids\": [\"23927931\", \"23737756\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How GLIS3 regulates SRp55 expression or activity unknown\", \"Whether the scaffold function is unique to the insulin promoter or general\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of Itch as a second E3 ubiquitin ligase for GLIS3 (acting via N-terminal PPxY motifs) complemented the earlier Cullin3 finding, revealing dual proteolytic control of GLIS3 protein levels that tunes insulin gene output.\",\n      \"evidence\": \"Mass spectrometry, yeast two-hybrid, co-IP, ubiquitination assays, proteasome inhibitor experiments, and mutagenesis\",\n      \"pmids\": [\"26147758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Relative contributions of Itch vs. Cullin3 in beta cells in vivo unknown\", \"No deubiquitinase identified\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"ChIP-Seq in thyroid placed GLIS3 downstream of TSH/TSHR signaling as a direct activator of iodide transporter genes (Nis, Pds) and revealed that GLIS3 is required for mTORC1-dependent thyroid proliferation, providing a molecular explanation for congenital hypothyroidism.\",\n      \"evidence\": \"GLIS3 ChIP-Seq in thyroid, mTORC1/RPS6 signaling analysis, and Glis3-deficient mouse thyroid phenotyping\",\n      \"pmids\": [\"29083325\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How TSH signaling induces GLIS3 expression or activity unknown\", \"mTORC1 activation mechanism downstream of GLIS3 not defined\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"SUMOylation of GLIS3 at conserved N-terminal lysines (by PIASy/Ubc9) was shown to inhibit insulin transcription under chronic high-glucose conditions, providing a post-translational mechanism linking glucotoxicity to beta cell dysfunction; concurrently, GLIS3 loss in hESC-derived beta cells was shown to activate TGFβ-mediated cell death, identifying a druggable pathway.\",\n      \"evidence\": \"SUMOylation assays with mutagenesis under variable glucose; GLIS3−/− hESC differentiation with chemical screen and xenograft rescue\",\n      \"pmids\": [\"30094379\", \"29992946\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"SUMO site occupancy in native beta cells not measured\", \"Identity of TGFβ ligands and receptors mediating GLIS3−/− beta cell death unresolved\", \"Drug target specificity not fully defined\"]\n    },\n    {\n      \"year\": 2019,\n      \"claim\": \"Genome-wide ChIP-Seq in beta cells expanded the direct GLIS3 target repertoire to include Slc2a2/Glut2 and MafA, showing that GLIS3 loss produces a PDX1+/INS−/MAFA−/GLUT2− dedifferentiated beta cell state rather than simply causing cell death, reshaping the understanding of GLIS3-associated diabetes pathogenesis.\",\n      \"evidence\": \"GLIS3 ChIP-Seq and RNA-Seq in islets from pancreas-specific conditional KO mice\",\n      \"pmids\": [\"31340201\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether dedifferentiated cells can be re-differentiated by GLIS3 restoration untested\", \"Distinction between dedifferentiation and alternative cell fate not resolved\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Integration of GLIS3, PAX8, NKX2.1, and FOXE1 cistromes in thyroid revealed extensive co-occupancy at thyroid gene regulatory regions; GLIS3 loss did not alter co-factor binding or histone marks, suggesting GLIS3 activates transcription by enhancing enhancer–promoter communication or Pol II recruitment rather than restructuring chromatin.\",\n      \"evidence\": \"Multi-TF ChIP-Seq in mouse thyroid and PCCl3 cells, histone mark ChIP-qPCR in Glis3 KO\",\n      \"pmids\": [\"36793061\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Enhancer–promoter looping assays (e.g., HiChIP) not performed\", \"Whether this non-chromatin-remodeling mechanism applies in beta cells unknown\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Discovery that GLIS3 directly controls mitochondrial biogenesis, OXPHOS, and fatty acid oxidation genes in kidney — co-binding with HNF1B and NRF1 — and that GLIS3 loss causes metabolic reprogramming toward aerobic glycolysis (via PKM2 de-repression) that drives cystogenesis, established a metabolic mechanism for GLIS3-associated polycystic kidney disease and a pharmacological target (PKM2 inhibition).\",\n      \"evidence\": \"ChIP-Seq, untargeted metabolomics, Seahorse respirometry, and PKM2 inhibitor rescue in tissue-specific KO mice and spheroid cultures\",\n      \"pmids\": [\"39505148\", \"41826646\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the metabolic switch is reversible in vivo with GLIS3 restoration not tested\", \"Contribution of other glycolytic enzymes beyond PKM2 unclear\", \"HNF1B and NRF1 functional interdependence with GLIS3 not dissected by combinatorial KO\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"Genome-wide CRISPR screens identified GLIS3 as a key transcriptional regulator of an inflammatory-fibrotic gene network in intestinal fibroblasts, extending its role beyond endocrine and renal tissues; fibroblast-specific Glis3 deletion alleviated chronic colitis, establishing GLIS3 as a driver of inflammation-associated fibrosis.\",\n      \"evidence\": \"CRISPR KO/activation screens, fibroblast-specific conditional KO mouse, single-cell and spatial transcriptomics in colitis model\",\n      \"pmids\": [\"41501466\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct GLIS3 target genes in fibroblasts not defined by ChIP\", \"Upstream signals (beyond FCN1+IL1B+ macrophages) inducing GLIS3 in fibroblasts unknown\", \"Relevance to human inflammatory bowel disease not established\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major unresolved questions include: the structural basis of GLIS3–DNA interaction and how its five zinc fingers cooperate; the cilia-to-nucleus signaling pathway that regulates GLIS3 processing or activation; and whether the metabolic, splicing-regulatory, and chromatin-remodeling functions of GLIS3 operate through common or distinct co-factor complexes across tissues.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No crystal or cryo-EM structure of GLIS3 zinc finger domain bound to DNA\", \"Ciliary signaling mechanism for GLIS3 activation entirely undefined\", \"Tissue-specific co-factor repertoire not systematically compared\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [0, 2, 4, 6, 12, 16, 20, 24, 25]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [0, 2, 4, 6, 10, 12, 16, 18, 20, 23, 24, 25, 30]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 2, 3, 4, 12]},\n      {\"term_id\": \"GO:0005929\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 2, 4, 6, 10, 12, 16, 18, 20, 23, 24, 25, 30]},\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [1, 5, 6, 14, 15, 26]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [16, 18, 19, 21, 27]},\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [7, 13, 17]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [24, 25]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [11, 19]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [1, 27, 30]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"PDX1\", \"MAFA\", \"NEUROD1\", \"HNF6\", \"FOXA2\", \"SUFU\", \"WWTR1\", \"ITCH\"],\n    \"other_free_text\": []\n  }\n}\n```"}